Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Opinion in Lipidology

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MOL.0000000000000293PMID 27031273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucagon‐like peptide‐1 preserves non‐alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress‐associated pathway

  2016cited by this paper
• Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up

  2016cited by this paper
• Dysfunctional HDL and atherosclerotic cardiovascular disease

  2016cited by this paper
• Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake.

  2016cited by this paper
• Alleviation of high-fat diet-induced atherosclerosis and glucose intolerance by a novel GLP-1 fusion protein in ApoE−/− mice

  2016cited by this paper
• Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study.

  2016cited by this paper
• Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

  2016cited by this paper
• The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.

  2015cited by this paper
• Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice.

  2015cited by this paper
• Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.

  2015cited by this paper
• Rapid and Body Weight–Independent Improvement of Endothelial and High-Density Lipoprotein Function After Roux-en-Y Gastric Bypass: Role of Glucagon-Like Peptide-1

  2015cited by this paper
• HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.

  2015cited by this paper
• Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

  2015cited by this paper
• Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance

  2015cited by this paper
• Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice

  2015cited by this paper
• Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism

  2015cited by this paper
• New Insights into the Regulation of Chylomicron Production.

  2015cited by this paper
• A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

  2015cited by this paper
• Dyslipidaemia of diabetes and the intestine.

  2015cited by this paper
• HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

  2015cited by this paper
• Rapid and Body Weight-Independent Improvement of Endothelial and HDL Function After Roux-enY Gastric Bypass : Role of Glucagon-Like Peptide-1 Running title :

  2015cited by this paper
• Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain–Gut Axis

  2015cited by this paper
• Exendin-4 regulates redox homeostasis in rats fed with high-fat diet.

  2015cited by this paper
• The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

  2014cited by this paper
• GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance

  2014cited by this paper
• Physiological Mechanisms behind Roux-en-Y Gastric Bypass Surgery

  2014cited by this paper
• An Overview of the New Frontiers in the Treatment of Atherogenic Dyslipidemias

  2014cited by this paper
• GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

  2014cited by this paper
• Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans

  2014cited by this paper
• Effect of liraglutide administration and a calorie-restricted diet on lipoprotein profile in overweight/obese persons with prediabetes.

  2014cited by this paper
• The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

  2014cited by this paper
• Glucagon-like peptide-2 regulates release of chylomicrons from the intestine.

  2014cited by this paper
• Roux‐en‐Y gastric bypass surgery increases number but not density of CCK‐, GLP‐1‐, 5‐HT‐, and neurotensin‐expressing enteroendocrine cells in rats

  2013cited by this paper
• The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model

  2013cited by this paper
• GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production

  2013cited by this paper
• Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats

  2013cited by this paper
• Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes

  2013cited by this paper
• Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice.

  2013cited by this paper
• Molecular mechanisms of incretin hormone secretion☆

  2013cited by this paper
• Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans

  2012cited by this paper
• A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.

  2012cited by this paper
• Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

  2012cited by this paper
• GLP-1 and energy balance: an integrated model of short-term and long-term control

  2011cited by this paper
• Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes

  2011cited by this paper
• Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.

  2011cited by this paper
• Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis

  2011cited by this paper
• Gastric bypass increases energy expenditure in rats.

  2010cited by this paper
• The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

  2010cited by this paper
• Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

  2009cited by this paper
• To be or not to be—an incretin or enterogastrone?

  2006cited by this paper
• Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

  2006cited by this paper
• Biologic actions and therapeutic potential of the proglucagon-derived peptides

  2005cited by this paper
• The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.

  2001cited by this paper
• Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

  1967cited by this paper

• Association of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Neurogenesis: A Systematic Review.

  2025cites this paper
• Discussion on the mechanism of Bao-Yuan Yang-Xin Decoction in treating coronary heart disease based on network pharmacology and molecular docking

  2025cites this paper
• Role of amylin in feeding and satiation.

  2025cites this paper
• Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders.

  2025cites this paper
• Metformin and the Liver: Unlocking the Full Therapeutic Potential

  2024cites this paper
• A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders.

  2024cites this paper
• Liraglutide alleviates high-fat diet-induced kidney injury in mice by regulating the CaMKKβ/AMPK pathway

  2024cites this paper
• Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?

  2023cites this paper
• Role of Enteroendocrine Hormones in Appetite and Glycemia.

  2021cites this paper
• Chlorogenic Acid: A Promising Natural Agent for Non-Alcoholic Fatty Liver Disease Management

  2021cites this paper
• Safety, tolerability, pharmacodynamics, and pharmacokinetics of CJC-1134-PC in healthy Chinese subjects and type-2 diabetic subjects

  2021cites this paper
• The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial

  2021cites this paper
• Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1

  2021cites this paper
• Lipid effects of glucagon-like peptide 1 receptor analogs

  2021cites this paper
• Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism.

  2020cites this paper
• LncRNA-Malat1 is involved in lipotoxicity-induced β-cell dysfunction and the therapeutic effect of exendin-4 via Ptbp1.

  2020cites this paper
• The Biological Role of Optimized Recombinant Oral Long-Acting Glucagon Like Peptide-1 and Its Impact on the Expression of Genes Associated with Glucose Metabolism of Diabetes

  2020cites this paper
• The Biological Role of Optimized Recombinant Oral Long-Acting Glucagon Like Peptide-1 and Its Impact on the Expression of Genes Associated with Glucose Metabolism of Diabetes

  2020cites this paper
• The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution.

  2019cites this paper
• Adiponectin/SIRT1 Axis Induces White Adipose Browning After Vertical Sleeve Gastrectomy of Obese Rats with Type 2 Diabetes

  2019cites this paper
• Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity.

  2019cites this paper
• (–)‐Epicatechin in the control of glucose homeostasis: Involvement of redox‐regulated mechanisms

  2019cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review

  2018cites this paper
• Fibres as functional foods and the effects on gut hormones: The example of β-glucans in a single arm pilot study

  2018cites this paper
• Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease

  2018cites this paper
• Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus

  2018cites this paper
• Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

  2018cites this paper
• Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice

  2018cites this paper
• Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review

  2018cites this paper
• Effect of Glucagon Like Peptide-1 on Serum Kisspeptin Level in Adult Male Albino Rats Treated by Anabolic Androgenic Steroid

  2018cites this paper
• Healthy eating as a strategy to achieve successful ageing: focus on Mediterranean diet and functional foods.

  2017cites this paper
• The regulatory role of DPP4 in atherosclerotic disease

  2017cites this paper
• Pathophysiology of Diabetic Dyslipidaemia.

  2017cites this paper
• Novel targets for the development of drugs for Type 2 Diabetes Mellitus

  2016cites this paper
• β-Glucans and Post Prandial Satiety: The Role of Intestinal Hormones in Healthy Volunteers

  2016cites this paper
• Selective beneficial cardiometabolic effects of vertical sleeve gastrectomy are predominantly mediated through glucagon-like peptide (GLP-1) in Zucker diabetic fatty rats

  2016cites this paper